Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM 100

680.00p
   
  • Change Today:
    -20.00p
  • 52 Week High: 1,220.00
  • 52 Week Low: 415.00
  • Currency: UK Pounds
  • Shares Issued: 72.24m
  • Volume: 37,412
  • Market Cap: £491.24m
  • RiskGrade: 348

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.
Competitors: Surgical Innovations, Immunodiagnostic Systems, Scientific Digital Imaging

Key Personnel

CEO: James Renwick McCullough
CFO: James Sterling
Chief Medical Officer: Michael Donovan
Chief Technical Officer: Fergus Fleming
Interim Chairman: Christopher H B Mills
President: Thomas McLain
Non-Executive Dir: Chirag R. Parikh, Ann E. Berman, Erik Kristian Lium, Daniel J. Levangie

Contact Details

Address: Avon House,19 Stanwell Road,Penarth,Cardiff,United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.renalytix.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-ShareFTSE AIM 100
ISIN: GB00BYWL4Y04

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 680.00p
Change Today -20.00p
% Change -2.86 %
52 Week High 1,220.00
52 Week Low 415.00
Volume 37,412
Shares Issued 72.24m
Market Cap £491.24m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
12.86% above the market average12.86% above the market average12.86% above the market average12.86% above the market average12.86% above the market average
41.46% above the sector average41.46% above the sector average41.46% above the sector average41.46% above the sector average41.46% above the sector average
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 24-Sep-2021

Time Volume / Share Price
16:23 7,000 @ 697.50p
15:55 7,500 @ 697.50p
16:35 700 @ 680.00p
16:29 1,000 @ 695.10p
16:04 2,268 @ 720.00p

RENX Key Personnel

CEO James Renwick McCullough
CFO James Sterling

Top of Page